Literature DB >> 32036243

Nanobodies to study protein conformational states.

Tomasz Uchański1, Els Pardon1, Jan Steyaert2.   

Abstract

Because of their small size and their beneficial biochemical and economic properties (size, affinity, specificity, stability, production cost), nanobodies are now increasingly used for routine and more innovative applications in research, biotechnology, and medicine. As they provide access to conformational epitopes in concave and hinge regions, nanobodies are also increasingly applied in structural biology to freeze dynamic proteins into single functional conformations. X-ray crystallography can then be used to determine the structures of different stills of the same moving biomolecule. Conformational nanobodies can also be introduced as intrabodies inside living cells as conformational biosensors for spatiotemporal analysis. By engineering these nanobodies in several ways, conformational nanobodies are now also amenable to single particle cryo-EM or to drive better-focused drug discovery.
Copyright © 2020. Published by Elsevier Ltd.

Mesh:

Substances:

Year:  2020        PMID: 32036243     DOI: 10.1016/j.sbi.2020.01.003

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  16 in total

1.  Modular transient nanoclustering of activated β2-adrenergic receptors revealed by single-molecule tracking of conformation-specific nanobodies.

Authors:  Rachel S Gormal; Pranesh Padmanabhan; Ravikiran Kasula; Adekunle T Bademosi; Sean Coakley; Jean Giacomotto; Ailisa Blum; Merja Joensuu; Tristan P Wallis; Harriet P Lo; Srikanth Budnar; James Rae; Charles Ferguson; Michele Bastiani; Walter G Thomas; Els Pardon; Jan Steyaert; Alpha S Yap; Geoffrey J Goodhill; Massimo A Hilliard; Robert G Parton; Frédéric A Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-19       Impact factor: 11.205

Review 2.  Exploring cellular biochemistry with nanobodies.

Authors:  Ross W Cheloha; Thibault J Harmand; Charlotte Wijne; Thomas U Schwartz; Hidde L Ploegh
Journal:  J Biol Chem       Date:  2020-08-31       Impact factor: 5.157

Review 3.  Finding the Perfect Fit: Conformational Biosensors to Determine the Efficacy of GPCR Ligands.

Authors:  Keith M Olson; Andra Campbell; Andrew Alt; John R Traynor
Journal:  ACS Pharmacol Transl Sci       Date:  2022-08-14

4.  Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.

Authors:  Fangling Ji; Jun Ren; Cécile Vincke; Lingyun Jia; Serge Muyldermans
Journal:  Methods Mol Biol       Date:  2022

5.  Production of Single-Domain Antibodies in Pichia pastoris.

Authors:  Yusei Matsuzaki; Kaho Kajiwara; Wataru Aoki; Mitsuyoshi Ueda
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Therapeutic Nanobodies Targeting Cell Plasma Membrane Transport Proteins: A High-Risk/High-Gain Endeavor.

Authors:  Raf Van Campenhout; Serge Muyldermans; Mathieu Vinken; Nick Devoogdt; Timo W M De Groof
Journal:  Biomolecules       Date:  2021-01-06

7.  Architecture of cell-cell junctions in situ reveals a mechanism for bacterial biofilm inhibition.

Authors:  Charlotte E Melia; Jani R Bolla; Stefan Katharios-Lanwermeyer; Daniel B Mihaylov; Patrick C Hoffmann; Jiandong Huo; Michael R Wozny; Louis M Elfari; Jan Böhning; Ashleigh N Morgan; Charlie J Hitchman; Raymond J Owens; Carol V Robinson; George A O'Toole; Tanmay A M Bharat
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 12.779

Review 8.  Advances in methods for atomic resolution macromolecular structure determination.

Authors:  Michael C Thompson; Todd O Yeates; Jose A Rodriguez
Journal:  F1000Res       Date:  2020-07-02

Review 9.  Recombinant expression of nanobodies and nanobody-derived immunoreagents.

Authors:  Ario de Marco
Journal:  Protein Expr Purif       Date:  2020-04-11       Impact factor: 1.650

Review 10.  Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments.

Authors:  Annamaria Sandomenico; Jwala P Sivaccumar; Menotti Ruvo
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.